Found 0 matching trials
Phase III Hallmark DUAL: ASV+DCV (Nulls/Partials, Intolerants/Ineligibles. Naives)
PHASE3The purpose of this study is to estimate efficacy, as determined by the pro...
Location
The Health Care Authority For Baptist Health
An Efficacy, Safety and Tolerability Study of TMC435 in Genotype 1 Hepatitis C-infected Patients Who Relapsed After Previous Therapy
PHASE3The purpose of this study is to investigate the effectiveness and safety of...
Location
Multiple Locations
An Efficacy, Safety, and Tolerability Study of TMC435 in Treatment-naive, Genotype 1 Hepatitis C-infected Participants
PHASE3The purpose of this study is to investigate the effectiveness and safety of...
Location
Multiple Locations
Dose Ranging Study of Pegylated Interferon Lambda in Patients With Hepatitis B and Positive for the Hepatitis B e Antigen
PHASE2At least 1 dose of pegIFNλ will be identified which is safe, well tolerated...
Location
Advanced Clinical Research Institute
Hepatitis B Immune Globulin (HBIg) to Restore Immune Control in People With Chronic Hepatitis B
PHASE2Background:
Hepatitis B is a viral infection of the liver. When the immune...
Location
National Institutes of Health Clinical Center
The Optimizing Treatment of PegIFN Alfa in HBeAg-negative CHB Patients With Low Level HBsAg
PHASE4As HBsAg clearance is uncommon in chronic hepatitis B (CHB) patients on nuc...
Location
The third affiliated hospital of Sun Yat-sen University
Switch or Sequential Combination Therapy of Peginterferon in Hepatitis B Patients With Longterm Entecavir Therapy
N/AThis is a multicenter, prospective cohort study to evaluate the efficacy an...
Location
The First Affiliated Hospital, Anhui Medical University
Study of SCY-635, Pegasys and Copegus in Hepatitis C
PHASE2This study will examine the effectiveness of 28 days of triple combination ...
Location
Quest Clinical Research
Pegylated Interferon(Peg-IFN) in Reducing Relapse Rate in Patients After Discontinuation of NUC Therapy
PHASE4This study evaluates whether Peg-IFN alfa-2a can reduce the recurrence rate...
Location
Wuhan Seventh People's Hospital
Retreatment With High Doses of pegIFN Alfa-2a and Ribavirin of Previous Nonresponders HIV-coinfected Patients With Cirrhosis Due to HCV 1-4
PHASE2Objective: To evaluate the efficacy and safety of high doses of both pegint...
Location
Hospital Universitario Reina Sofía